Loading…
Evolent Health, Inc. is projected to rise to $4.11 by 2027, a +10% move from its current price of $3.72. EVH is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $3.59 | $3.72 | $3.86 | +0.08% |
| May 30 | $3.54 | $3.73 | $3.92 | +0.17% |
| May 31 | $3.50 | $3.73 | $3.97 | +0.25% |
| Jun 1 | $3.47 | $3.73 | $4.01 | +0.33% |
| Jun 2 | $3.45 | $3.74 | $4.05 | +0.41% |
| Jun 3 | $3.42 | $3.74 | $4.08 | +0.50% |
| Jun 4 | $3.40 | $3.74 | $4.12 | +0.58% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.40 | $3.74 | $4.12 | +0.58% |
| Week 2 | $3.29 | $3.76 | $4.31 | +1.17% |
| Week 3 | $3.21 | $3.79 | $4.47 | +1.75% |
| Week 4 | $3.15 | $3.81 | $4.61 | +2.34% |
| Week 5 | $3.09 | $3.83 | $4.74 | +2.94% |
| Week 6 | $3.05 | $3.85 | $4.87 | +3.54% |
| Week 7 | $3.01 | $3.87 | $4.99 | +4.14% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers an integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.
In addition, the company provides Machinify Auth Intelligence, an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
EVH trades at $3.95 per share. It has a market cap of $444.3M and is ranked 3128. The price outlook from the provided forecast shows near-term neutral in 2026 with an avg price of $3.95, and gradual upside thereafter, reaching an average of $11.09 by 2040 and $15.60 by 2050. These figures are estimates and not guarantees.
A major floor 41.7% below — a decisive break under it would weaken the trend.
The nearest floor, 23.7% below — buyers have tended to step in here.
The nearest ceiling, 14.8% above — a clean break opens room to run.
A major ceiling 35.5% above — clearing it would confirm fresh momentum.
Key EVH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of EVH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.84 | Sell | $3.83 | Sell |
| MA 10 | $3.92 | Sell | $3.87 | Sell |
| MA 20 | $3.94 | Sell | $3.78 | Sell |
| MA 50 | $3.17 | Buy | $3.49 | Buy |
| MA 100 | $3.25 | Buy | $3.72 | Sell |
| MA 200 | $5.05 | Sell | $5.21 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 51.10 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -116.21 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.07 | Sell |
| ROC (12) | -11.00 | Sell |
| Bollinger %B (20,2) | 0.14 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 1.12 | Buy |
| Awesome (5,34) | 0.32 | Buy |
| Ultimate (7,14,28) | 35.59 | Neutral |
| Momentum (10) | -0.44 | Sell |
| Aroon Osc (25) | 40.00 | Buy |
| Hull MA (9) | 3.81 | Sell |
| ADX (14) | 23.61 | Buy |
| ATR (14) | 0.11 | Info |
Technical sentiment is NEUTRAL. RSI14 is 60. The 50-day simple moving average is $3.14 and the 200-day simple moving average is $5.10. The current price sits above the $3.14 SMA50 and below the $5.10 SMA200. The 30-day range is $3.09 to $5.06, with a support at $2.51 and a resistance at $4.27.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.17 | $3.72 | $5.32 | 0% | Neutral | |
| $3.16 | $4.11 | $5.72 | +10% | Neutral | |
| $3.24 | $4.38 | $6.38 | +18% | Neutral | |
| $3.06 | $4.26 | $6.43 | +15% | Neutral | |
| $2.72 | $3.90 | $6.06 | +5% | Neutral | |
| $3.35 | $4.93 | $7.86 | +33% | Bullish | |
| $3.86 | $5.81 | $9.49 | +56% | Bullish | |
| $3.90 | $6.01 | $10.02 | +62% | Bullish | |
| $4.22 | $6.65 | $11.30 | +79% | Bullish | |
| $3.92 | $6.31 | $10.92 | +70% | Bullish | |
| $5.64 | $10.02 | $18.65 | +169% | Bullish | |
| $6.69 | $14.19 | $29.39 | +281% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $2.17 | $3.72 | $4.38 | +0.00% |
| June 2026 | $3.21 | $3.79 | $4.61 | +1.93% |
| July 2026 | $3.35 | $4.01 | $4.96 | +5.80% |
| August 2026 | $3.36 | $4.06 | $5.09 | +1.17% |
| September 2026 | $3.26 | $3.96 | $5.02 | -2.53% |
| October 2026 | $3.29 | $4.02 | $5.15 | +1.67% |
| November 2026 | $3.37 | $4.15 | $5.36 | +3.16% |
| December 2026 | $3.30 | $4.09 | $5.32 | -1.43% |
Click any year to see its month-by-month EVH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The EVH price prediction for 2026 points to an average of $3.72 (low $2.17, high $5.32) — a potential gain of 0% on today's $3.72. Price action looks broadly range-bound.
In 2027, EVH is projected to trade between $3.16 and $5.72, averaging $4.11 — a potential gain of +10% from today's $3.72. That is up +10% on the projected 2026 average. A consolidation phase looks the most probable path here.
Evolent Health, Inc.'s 2028 outlook centres on $4.38, within a $3.24 to $6.38 range. That is up +7% on the projected 2027 average. That marks a +18% change versus current levels. Price action looks broadly range-bound.
By 2029, EVH could reach as high as $6.43, with a base case around $4.26 and support toward $3.06 — roughly +15% from $3.72. A consolidation phase looks the most probable path here.
Expect EVH to range from $2.72 to $6.06 through 2030. The $3.90 average target implies a +5% move from current prices. That is -8% versus the projected 2029 average. Price action looks broadly range-bound.
The EVH price prediction for 2031 points to an average of $4.93 (low $3.35, high $7.86) — a potential gain of +33% on today's $3.72. Buyers look set to stay in control over this stretch.
In 2032, EVH is projected to trade between $3.86 and $9.49, averaging $5.81 — a potential gain of +56% from today's $3.72. That is up +18% on the projected 2031 average. Momentum favours further upside here.
Evolent Health, Inc.'s 2033 outlook centres on $6.01, within a $3.90 to $10.02 range. That is up +3% on the projected 2032 average. That marks a +62% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, EVH could reach as high as $11.30, with a base case around $6.65 and support toward $4.22 — roughly +79% from $3.72. Momentum favours further upside here.
Expect EVH to range from $3.92 to $10.92 through 2035. The $6.31 average target implies a +70% move from current prices. That is -5% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
The EVH price prediction for 2040 points to an average of $10.02 (low $5.64, high $18.65) — a potential gain of +169% on today's $3.72. Momentum favours further upside here.
In 2050, EVH is projected to trade between $6.69 and $29.39, averaging $14.19 — a potential gain of +281% from today's $3.72. That is up +42% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in EVH today (≈ 268.817204 EVH) could be worth
$3,814.01
+$2,814.01 (+281%) by 2050 · US Dollar
Based on the average projected EVH price of $14.19 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in EVHwould be worth at today's price.
$1,000 invested in EVH on May 27, 2025 (≈ 129.870133 EVH) would be worth
$483.12
-$516.88 (-51.7%) today · 0.48× · US Dollar
Based on a EVH entry price of $7.7 vs. today's $3.72.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.86 | $963.73 | -3.6% |
| 1 month ago | $3.47 | $1,072.05 | +7.2% |
| 3 months ago | $3.32 | $1,120.48 | +12.0% |
| 6 months ago | $4.2 | $885.71 | -11.4% |
| 1 year ago | $7.7 | $483.12 | -51.7% |
| All time (5.0y) ago | $19.37 | $192.05 | -80.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our EVH forecast.
Our base-case forecast reaches $7.40 around 2040.
Implied market cap at $7.40: $832.36M
The multi-year forecast shows a path of rising averages beginning in 2026. In 2026 the average price is $3.95, with a min of $2.17 and a max of $5.67 and ROI 0; sentiment NEUTRAL. 2027 shows an average of $4.41 with ROI 11.5, 2028 an average of $4.67 with ROI 18.4, 2029 an average of $4.52 with ROI 14.5, and 2030 an average of $4.21 with ROI 6.5.
Tap a question to reveal the answer.
The forecast for 2030 shows an average price of $4.21, with a min of $2.91 and a max of $6.60; ROI 6.5; sentiment NEUTRAL.
Near-term outlook (2026) is NEUTRAL with an average of $3.95; from 2031 onward sentiment is BULLISH with higher averages and ROIs (2031 avg $5.38, ROI 36.3; 2050 avg $15.60, ROI 294.9). These are estimates and not guarantees.
Yes. The forecast shows a max of $10.47 in 2032 and $11.08 in 2033, with a higher max of $20.96 in 2040 and $32.87 in 2050.
For 2026, the min is $2.17, the avg is $3.95, and the max is $5.67. The 30-day range is $3.09 to $5.06, current price is $3.95.
Current price is $3.95, market cap is $444.3M, and rank is 3128.
Evolent Health, Inc. Community Discussion
0Share your Evolent Health, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.